All posts tagged "Feng Ren Chief Scientific Officer and head of drug discovery of Insilico"

Insilico Medicine Collaborates with BioNova to Develop Small Molecule Drugs for Hematologic Malignancies

  Insilico Medicine (“Insilico”), an end-to-end artificial intelligence-driven drug discovery company, and BioNova Pharmaceuticals (Shanghai) Ltd. (“BioNova”), a clinical-stage biopharmaceutical company, today announced entry into a collaboration...